INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE
ORDER A TEST Log In Contact Us

Tempus PRO™

Get the complete picture for mental health treatment response

Tempus PRO™ is a digital tool that automatically combines patient response to evidence-based screening assessments, with objective insights from patient lifestyle data. You can now easily and accurately measure patient treatment response over time to deliver better mental health care.1

Order Now

Patient lifestyle data and feedback on medication response are critical inputs for mental health treatment.2 But, maintaining touch-points and documentation with your patient in between appointments is hard.

Tempus PRO™ is a digital tool that automatically combines patient response to evidence-based screening assessments, with objective insights from patient lifestyle data. You can now easily track your patient’s response to your selected treatment in between appointments.

image description

Track patient response to your selected treatment

Objective insights from patient lifestyle data
  • View summarized data such as sleep quality, mood, and daily steps to get a holistic view of patient response to your selected treatment
  • Ability to integrate with your patient’s smartphone fitness tracker
    Apple Health Badge
image description
Library of over 90 digital assessments
  • Evidence based assessments such as the Frequency Intensity Burden of Side Effects Rating (FIBSER) to monitor adverse drug reaction, Vanderbilt Scale for ADHD, ACE Questionnaire for PTSD, and more
  • Assessments for depression, anxiety, ADHD, and other conditions
  • Automatically assign and score digital screeners and worksheets
image description
Patient friendly interface
  • Assessments and worksheets can be completed within a few minutes
  • Reminders for your patient to check-in and log any side effects, progress, and overall well-being
image description
Summarized results tracked over time
  • Visualize assessment response to quickly identify if your patient is responding to treatment
image description

A recent real-world data analysis showed Tempus PRO™ used in combination with pharmacogenomic (PGx) testing is associated with a significant decrease in symptom severity (-9%, matched pairs t-test p=1e-10).

Additionally, patients who received PGx testing showed higher engagement and retention with Tempus PRO™, with an average of 8.9 assessments completed over a retention period of 80 days.1

Get the White Paper

How it works

Tempus PRO™ is a part of the Tempus mental health platform.

See how it works

Ready to deliver better mental health care with Tempus?

Our pharmacogenomic test can optimize medication and dose selection, while Tempus PRO™ can track your patient’s response to your selected treatment in between appointments.1

Order Now
New to Tempus? Connect with our team
image description

View Frequently Asked Questions

Does my patient need a smartphone to access Tempus PRO™?

No. Patients can access Tempus PRO™ through a web portal. Patients with iPhones may download the Tempus PRO™ app from the Apple App Store.

Is there an extra cost to use Tempus PRO™?

No. Tempus PRO™ is included as a part of the Tempus personalized medicine platform and can be added to every Tempus nP PGx order. Patients may complete unlimited Tempus PRO™ assessments.

How do I know which assessment to add for my patient?

Medically standard assessments like PHQ-9 and GAD-7 are automatically suggested when you enroll your patient. If you want to learn more about available assessments, you can set up time with the Tempus Medical Affairs team.

Can I change the frequency of when my patient completes assessments?

The frequency for assessments can be customized and changed throughout your patient’s treatment. View “Patient Settings” in your Tempus Hub to modify assessments.

Do I have to enroll my patient in Tempus PRO™ in order to use Tempus pharmacogenomic (PGx) testing?

You do not need to use Tempus PRO™ along with Tempus pharmacogenomic testing. However, symptom severity does decrease following pharmacogenomic testing combined with Tempus PRO™.1

How is data from Tempus PRO™ used?

Your patient’s identifiable health information collected through Tempus PRO™ is protected in accordance with HIPAA requirements and kept confidential. De-identified data from Tempus PRO is used to improve the way mental health is diagnosed and treated. De-identified data may be used in research and in the development of new drugs, therapies, and analytical tools. Tempus’ notice of privacy practices is available here.

  1. Preliminary Results of Symptom Tracking using TempusPROTM of Patients with PGx Testing From a Real-World Clinical Dataset Poster. Psych Congress 2022 September 17-20, 2022 New Orleans.
  2. Walsh R. Lifestyle and mental health. Am Psychol. 2011 Oct;66(7):579-92. doi: 10.1037/a0021769. PMID: 21244124

Note: Tempus PRO™ is for patients who are age 13 and older.

This is data-driven precision medicine

This is the future of healthcare.